BrainRoute integrates machine learning prediction with community-driven verification of blood-brain barrier permeability
Year: 2026
Type: preprint
Abstract: The blood-brain barrier (BBB) is a highly selective barrier that restricts the entry of many therapeutic agents into the brain. The lack of efficient methods for BBB permeability research and data management remains a significant challenge for central nervous system drug-development pipelines. Although BBB permeability data are available from multiple open sources, few platforms integrate these datasets with molecular exploration, predictive tools, and a structured process for community-supported data verification. Here, we present BrainRoute, an open platform for BBB molecular data collection, exploration, prediction, and community-supported verification. BrainRoute provides searchable and filterable molecular records, physicochemical and structural information, source-linked data, single-molecule and batch prediction, and a structured workflow through which users can submit additional evidence for review. The prediction tool model-development cohort contained 7,888 unique molecules, including 5,424 BBB+ and 2,464 BBB- molecules. Six machine-learning classifiers were evaluated using PaDEL descriptors, Morgan fingerprints, frozen ChemBERTa embeddings, and combined feature representations. The three selected models were integrated into the platform as a probability-averaged ensemble. The primary five-fold scaffold-grouped analysis achieved a best mean balanced accuracy of 0.783 ± 0.026. On an independent external set containing 410 non-overlapping molecules, the deployed ensemble achieved a balanced accuracy of 0.659 (95% CI 0.600 - 0.712) and an AUPRC of 0.670 (95% CI 0.583 - 0.752). BrainRoute serves as a platform for exploring BBB-related molecular data and computational predictions while supporting the continued growth and verification of the underlying dataset. BrainRoute is freely accessible online (https://github.com/omicscodeathon/brainroutedb).
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W7237219871
